Li-Xuan Qin Selected Research

Neoplasms, Cystic, Mucinous, and Serous

3/2011	Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
11/2009	Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Xuan Qin Research Topics

Disease

45	Neoplasms (Cancer) 01/2024 - 11/2007
18	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 11/2007
6	Liposarcoma 09/2023 - 01/2013
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 02/2012
5	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2007
5	Rectal Neoplasms (Rectal Cancer) 04/2024 - 10/2023
4	Adenocarcinoma 04/2024 - 10/2023
4	Carcinogenesis 11/2023 - 03/2008
4	Neurofibrosarcoma (MPNST) 01/2019 - 07/2009
3	Aggressive Fibromatosis (Desmoid) 11/2023 - 10/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 06/2011
3	Anemia 01/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 10/2020 - 07/2012
3	Synovial Sarcoma (Synovioma) 10/2020 - 12/2008
2	Colonic Neoplasms (Colon Cancer) 11/2023 - 01/2009
2	Fibroma (Fibromatosis) 11/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 07/2012
2	Fever (Fevers) 11/2022 - 01/2019
2	Fatigue 11/2022 - 11/2015
2	Edema (Dropsy) 01/2022 - 01/2019
2	Hypophosphatemia 01/2022 - 01/2022
2	Exanthema (Rash) 01/2022 - 01/2022
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2014 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012 - 11/2009
2	Neoplasms, Cystic, Mucinous, and Serous 03/2011 - 11/2009
2	Neuroblastoma 06/2010 - 07/2009
2	Hemangiosarcoma (Angiosarcoma) 09/2009 - 07/2009
1	Residual Neoplasm 11/2023
1	Hypoxia (Hypoxemia) 11/2023
1	Pneumonia (Pneumonitis) 10/2023
1	Hypersensitivity (Allergy) 10/2023
1	Hypothyroidism 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Injection Site Reaction 11/2022
1	Neoplasm Micrometastasis 11/2022
1	Leiomyosarcoma 01/2019
1	Myocardial Infarction 01/2019
1	Hyperphosphatemia 01/2019

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2008
6	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2008
6	RNA (Ribonucleic Acid)IBA 10/2023 - 08/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
5	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 02/2012
3	Trinitrotoluene (TNT)IBA 04/2024 - 01/2024
3	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 07/2009
3	binimetinibIBA 01/2022 - 10/2019
3	Phosphotransferases (Kinase)IBA 01/2019 - 07/2009
2	CateninsIBA 11/2023 - 10/2015
2	pembrolizumabIBA 01/2023 - 01/2020
2	AntibodiesIBA 11/2022 - 03/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 11/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 11/2017
2	coactivator-associated arginine methyltransferase 1IBA 10/2020 - 10/2019
2	B7-H1 AntigenIBA 01/2020 - 03/2015
2	palbociclibIBA 07/2016 - 06/2013
2	Gemcitabine FDA Link 11/2015 - 01/2015
2	Docetaxel (Taxotere)FDA Link 11/2015 - 01/2015
1	Becaplermin (PDGF-BB)FDA Link 11/2023
1	Transaminases (Aminotransferases)IBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	abemaciclibIBA 09/2023
1	epacadostatIBA 01/2023
1	DioxygenasesIBA 01/2023
1	indoleIBA 01/2023
1	GangliosidesIBA 11/2022
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 11/2022
1	VaccinesIBA 11/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	bempegaldesleukinIBA 01/2022
1	CreatinineIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	NivolumabIBA 01/2022
1	HhAntag691IBA 01/2022
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 10/2020
1	talimogene laherparepvecIBA 01/2020
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	pexidartinibIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	infigratinibIBA 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Proto-Oncogene Proteins c-mdm2IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017
1	Methionine Sulfoxide ReductasesIBA 11/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017
1	AntioxidantsIBA 11/2017

Therapy/Procedure

15	Therapeutics 11/2023 - 02/2008
10	Drug Therapy (Chemotherapy) 11/2023 - 11/2007
6	Neoadjuvant Therapy 04/2024 - 11/2015
4	Radiotherapy 07/2015 - 01/2013
3	Induction Chemotherapy 01/2024 - 07/2009
2	Consolidation Chemotherapy 01/2024 - 10/2023
2	Aftercare (After-Treatment) 11/2023 - 02/2011
1	Metastasectomy 11/2022
1	Cryosurgery 01/2022
1	Drug Tapering 01/2019